Oncology IV compounding
Patient-specific oncology compounding, automated.
WEINAS Onco automates patient-specific and oncology IV compounding inside a closed ISO Class 5 environment. It protects pharmacists from cytotoxic exposure while supporting accurate, traceable doses.
- Patient-specific and oncology drug compounding
- 30–60 seconds per vial or ampoule
- 194 patents and more than 7 years of clinical application
- Closed ISO Class 5 (Class 100) compounding environment
WEINAS Onco IV Compounding Robot30–60 sPer vial or ampoule
194Patents
7+ yearsClinical use
608,629Doses since 2016
Key capabilities
WEINAS Onco IV Compounding Robot
- Patient-specific and oncology drug compounding
- 30–60 seconds per vial or ampoule
- 194 patents and more than 7 years of clinical application
- Closed ISO Class 5 (Class 100) compounding environment
- Barcode and robotic visual checks
- Dose accuracy verification and traceable records
Applications
Hospital PIVAS; oncology pharmacy; chemotherapy compounding; clinical trials
Specifications
WEINAS Onco IV Compounding Robot
| Item | Specification |
|---|---|
| Model | WEINAS Onco |
| Application | Patient-specific and oncology IV compounding |
| Speed | 30–60 seconds per vial or ampoule |
| Environment | Closed ISO Class 5 / Class 100 |
| Patents | 194 |
| Clinical use | More than 7 years |
| Safety | Closed compounding; robotic visual and barcode checks |
| Traceability | Prescription, drug and compounding records |
WEINAS Onco IV Compounding Robot is configured for PIVAS workflow and local requirements. Confirm the final configuration with FulCare.
Oncology IV compounding
WEINAS Onco IV Compounding Robot
Plan the robot configuration for your PIVAS workflow.